Bucknell Forum Series Hosts Talk by World-renowned Stem Cell Researcher
March 21, 2014
Bucknell alumnus Dr. David Scadden, a world leader in stem cell research and co-founder of the Harvard Stem Cell Institute, will give the talk, "Renewable You: Stem Cells and the Future of Medicine," Tuesday, March 25, at 7:30 p.m. in Trout Auditorium of the Vaughan Literature Building at Bucknell University.
The event, which is free and open to the public, is part of the University's ongoing Bucknell Forum series tech/no, which focuses on the evolution of technology's role in society, and its potential to impact the world in both positive and negative ways. Scadden's talk will include a question-and-answer session.
Scadden, who is the Gerald and Darlene Jordan Professor of Medicine at Harvard University, graduated from Bucknell with a degree in English in 1975. After attending Columbia University for a year of pre-medical studies, he received his medical degree from Case Western Reserve School of Medicine in 1980.
An expert in how viruses can lead to cancer, Scadden led an international consortium defining new ways to treat the cancers that emerge in the settings of immune deficiency. When it became clear that stem cells had the potential to treat a wide range of diseases, he joined with Dr. Douglas Melton to co-found the Harvard Stem Cell Institute, the largest stem cell program in the world.
Scadden is an expert on the medical applications of stem cell biology with an emphasis on their use in the settings of cancer and AIDS. He has published more than 250 scientific papers and book chapters, and therapies developed by his work are used in the treatment of cancer patients with immunodeficiency worldwide. He also developed a course for undergraduates combining literature and science and teaches undergraduates, graduate students and post-doctoral fellows.
Scadden has received numerous honors, including membership in the Institute of Medicine of the National Academies of Science, and serves on numerous professional boards, including the Board of Scientific Counselors for the National Cancer Institute. He is also a scientific founder of Fate Therapeutics, a private biotechnology company, and holds more than 20 patents.
A member of the Bucknell Board of Trustees since 2008, in 2010 he was honored by Bucknell University's Alumni Association with the Award for Outstanding Achievement in a Chosen Profession.
The following links are virtual breadcrumbs marking the 27 most recent pages you have visited in Bucknell.edu. If you want to remember a specific page forever click the pin in the top right corner and we will be sure not to replace it. Close this message.